Business
Cannabics Pharmaceuticals Hires Chief Data Officer to Address Industry Compliance and Utilization/Analytics Application
Cannabics Pharmaceuticals Hires Chief Data Officer to Address Industry Compliance and Utilization/Analytics Application.
About this update from Cnbx Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCannabics Pharmaceuticals Hires Chief Data Officer to Address Industry Compliance and Utilization/Analytics Application\n\n\n\n\n\nCannabics Pharmaceuticals Hires Chief Data Officer to Address Industry Compliance and Utilization/Analytics Application\nSupportive data is crucial to the company's provision of novel personal diagnostic tools for cannabinoid-based therapy for cancer\nPR Newswire\nTEL AVIV, Israel and BETHESDA, Maryland, February 20, 2018\n\n\n\nTEL AVIV, Israel and BETHESDA, Maryland, February 20, 2018 /PRNewswire/ --\n\nCannabics Pharmaceuticals Inc. (CNBX), a US public biotechnology company dedicated to the development of personalized anti-cancer diagnostics and palliative treatments based on the therapeutic properties of cannabis, announced the appointment of Yasha Borstein as the company's Chief Data Officer.\n\n     (Logo: http://mma.prnewswire.com/media/485543/Cannabics_Logo.jpg )\n\n\nWith extensive experience spanning big data analytics, machine learning, AI and software development alongside an extended track record in enterprise risk management, Yasha Borstein will oversee the design and implementation of a data governance policy for the company.\n\nAt the company's R&D base in Israel, Cannabics is conducting scientific research on cannabinoid formulations to deliver innovative diagnostic procedures for screening cancer. Utilizing advanced detection systems and personalized bioinformatics tools, the biotech company is engaged in delivering supportive data upon which cancer patients and doctors can make informed choices about treatments and possible side effects.\n\n\"My challenge is to maximize the value of the highly sensitive data generated by Cannabics as well as ensuring the highest standards of regulatory health compliance and data governance,\" says Yasha Borstein. \"The role presents an exciting opportunity to assist in the advancement of a new approach to cancer Theranostics\".\n\n\"We're delighted to welcome Yasha to the team as we continue to utilize the latest technologies to conduct research, and collect insightful data that deepens our knowledge and expands our IP portfolio,\" says Cannabics newly appointed CEO Eyal Barad. \"We believe we have engaged the very best and brightest scientists to explore the use of bioinformatic tools to support personalized cannabi...